Daihan Pharmaceutical Coltd Stock Annual Yield
023910 Stock | KRW 28,500 50.00 0.18% |
Daihan Pharmaceutical CoLtd fundamentals help investors to digest information that contributes to Daihan Pharmaceutical's financial success or failures. It also enables traders to predict the movement of Daihan Stock. The fundamental analysis module provides a way to measure Daihan Pharmaceutical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Daihan Pharmaceutical stock.
Daihan |
Daihan Pharmaceutical CoLtd Company Annual Yield Analysis
Daihan Pharmaceutical's Yield generally refers to the amount of cash that is paid back to the owner of a security over a specific time (usually one year). It is expressed as a percentage of current market price, and usually amounts to all the interests and/or dividends paid over a given period. A higher yield allows the shareholders to generate returns on their investments sooner. However, investors should also be aware that a high yield may be a result of market turmoil or increased price volatility.
Current Daihan Pharmaceutical Annual Yield | 0.01 % |
Most of Daihan Pharmaceutical's fundamental indicators, such as Annual Yield, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Daihan Pharmaceutical CoLtd is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Small firms, start-ups, or companies with high growth potential typically do not pay out dividends or distribute a lot of their profits. These companies will have small yield. Alternatively, more established companies, ETFs, and funds that invest in bonds will have higher yields.
Competition |
In accordance with the recently published financial statements, Daihan Pharmaceutical CoLtd has an Annual Yield of 0.0138%. This is much higher than that of the Healthcare sector and significantly higher than that of the Pharmaceuticals industry. The annual yield for all Republic of Korea stocks is notably lower than that of the firm.
Daihan Annual Yield Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Daihan Pharmaceutical's direct or indirect competition against its Annual Yield to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Daihan Pharmaceutical could also be used in its relative valuation, which is a method of valuing Daihan Pharmaceutical by comparing valuation metrics of similar companies.Daihan Pharmaceutical is currently under evaluation in annual yield category among related companies.
Daihan Fundamentals
Return On Equity | 12.49 | |||
Return On Asset | 0.0677 | |||
Profit Margin | 0.10 % | |||
Operating Margin | 0.17 % | |||
Current Valuation | 148.23 B | |||
Shares Outstanding | 6 M | |||
Shares Owned By Insiders | 34.84 % | |||
Shares Owned By Institutions | 13.66 % | |||
Price To Earning | 11.74 X | |||
Price To Sales | 0.93 X | |||
Revenue | 171.46 B | |||
Gross Profit | 56.19 B | |||
EBITDA | 39.72 B | |||
Net Income | 22.67 B | |||
Cash And Equivalents | 83.73 B | |||
Total Debt | 14 B | |||
Debt To Equity | 0.15 % | |||
Current Ratio | 3.12 X | |||
Cash Flow From Operations | 40.62 B | |||
Target Price | 58000.0 | |||
Beta | 0.53 | |||
Market Capitalization | 182.1 B | |||
Total Asset | 272.54 B | |||
Retained Earnings | 67.17 B | |||
Working Capital | 33.04 B | |||
Current Asset | 75.05 B | |||
Current Liabilities | 42.01 B | |||
Z Score | 7.8 | |||
Annual Yield | 0.01 % | |||
Net Asset | 272.54 B |
About Daihan Pharmaceutical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Daihan Pharmaceutical CoLtd's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Daihan Pharmaceutical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Daihan Pharmaceutical CoLtd based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Daihan Pharmaceutical in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Daihan Pharmaceutical's short interest history, or implied volatility extrapolated from Daihan Pharmaceutical options trading.
Thematic Opportunities
Explore Investment Opportunities
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Daihan Pharmaceutical CoLtd. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.
Complementary Tools for Daihan Stock analysis
When running Daihan Pharmaceutical's price analysis, check to measure Daihan Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Daihan Pharmaceutical is operating at the current time. Most of Daihan Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Daihan Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Daihan Pharmaceutical's price. Additionally, you may evaluate how the addition of Daihan Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings |